Literature DB >> 10612463

Chromatin remodelling and nuclear reprogramming at the onset of embryonic development in mammals.

J P Renard1.   

Abstract

Two main strategies are used to produce cloned mammals. The first involves the condensation of donor chromatin into chromosomes directly exposed to the recipient cytoplasm, whereas the second leaves the donor nucleus in interphase until the time of the first mitosis. Both strategies, which induce marked changes in chromatin organization, allow full reprogrammation of somatic-differentiated fetal and adult cells. This paper reviews some of the recent data that contribute to our understanding of chromatin remodelling at the onset of normal development, as well as after the introduction of a foreign nucleus into a recipient enucleated oocyte. These data indicate that the coordinated changes in chromatin organization that take place up until the first cellular differentiations at the blastocyst stage are determinants for successful cloning. Although some degree of synchronization between the cell cycle stages of donor and recipient cells is necessary for correct remodelling of a transferred nucleus, the kinetics of remodelling events occurring during the one-cell stage appears to be the determining factor for the normal onset of gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10612463     DOI: 10.1071/rd98086

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  3 in total

Review 1.  Advances in reprogramming somatic cells to induced pluripotent stem cells.

Authors:  Minal Patel; Shuying Yang
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

2.  In vitro matured oocytes are more susceptible than in vivo matured oocytes to mock ICSI induced functional and genetic changes.

Authors:  Shubhashree Uppangala; Shilly Dhiman; Sujit Raj Salian; Vikram Jeet Singh; Guruprasad Kalthur; Satish Kumar Adiga
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 3.  Transgenic nonhuman primates for neurodegenerative diseases.

Authors:  Anthony W S Chan
Journal:  Reprod Biol Endocrinol       Date:  2004-06-16       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.